AHF Demands Gilead Drop Exclusive ‘Orphan Drug’ Claim on COVID-19 Treatment

AIDS Healthcare Foundation ( AHF ) today is calling on Gilead Sciences Inc. , one of the largest manufacturers of HIV/AIDS drugs, to immediately abandon its claim for orphan drug designation for remdesivir, an antiviral drug thought to have some promise in the treatment of COVID-19.